BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17225094)

  • 1. Recombinant therapeutic antibodies.
    Dübel S
    Appl Microbiol Biotechnol; 2007 Mar; 74(4):723-9. PubMed ID: 17225094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully in vitro selection of recombinant antibodies.
    Moutel S; Vielemeyer O; Jin H; Divoux S; Benaroch P; Perez F
    Biotechnol J; 2009 Jan; 4(1):38-43. PubMed ID: 19156724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioprocessing using novel cell culture systems.
    Parekh S; Srinivasan V; Horn M
    Adv Appl Microbiol; 2008; 63():105-43. PubMed ID: 18395126
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant antibody mixtures: production strategies and cost considerations.
    Rasmussen SK; Næsted H; Müller C; Tolstrup AB; Frandsen TP
    Arch Biochem Biophys; 2012 Oct; 526(2):139-45. PubMed ID: 22820097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.
    Kanda Y; Imai-Nishiya H; Kuni-Kamochi R; Mori K; Inoue M; Kitajima-Miyama K; Okazaki A; Iida S; Shitara K; Satoh M
    J Biotechnol; 2007 Jun; 130(3):300-10. PubMed ID: 17559959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins improving recombinant antibody production in mammalian cells.
    Nishimiya D
    Appl Microbiol Biotechnol; 2014 Feb; 98(3):1031-42. PubMed ID: 24327213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane technology for purification of therapeutic proteins.
    Zydney AL
    Biotechnol Bioeng; 2009 Jun; 103(2):227-30. PubMed ID: 19384928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Display technologies expand their horizons.
    Bradbury A
    Trends Biotechnol; 1999 Apr; 17(4):137-8. PubMed ID: 10203770
    [No Abstract]   [Full Text] [Related]  

  • 12. Yeast systems biotechnology for the production of heterologous proteins.
    Graf A; Dragosits M; Gasser B; Mattanovich D
    FEMS Yeast Res; 2009 May; 9(3):335-48. PubMed ID: 19341379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits and risks of antibody and vaccine production in transgenic plants.
    Warzecha H; Mason HS
    J Plant Physiol; 2003 Jul; 160(7):755-64. PubMed ID: 12940544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Going into production.
    Clayton J
    Nature; 2003 Dec; 426(6967):727. PubMed ID: 14668883
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmid-encoded protein: the principal factor in the "metabolic burden" associated with recombinant bacteria. Biotechnology Bioengineering, 1990.
    Bentley WE; Mirjalili N; Andersen DC; Davis RH; Kompala DS
    Biotechnol Bioeng; 2009 Apr; 102(5):1284-97; discussion 1283. PubMed ID: 19215036
    [No Abstract]   [Full Text] [Related]  

  • 16. Prestige Antibodies--monospecific antibodies designed for immunohistochemical analysis.
    Gunnerås S; Agaton C; Djerbi S; Hansson M
    Biotechniques; 2008 Mar; 44(3):427-30. PubMed ID: 18361797
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of fermentation process for rDNA products.
    Cossar D
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):756-9. PubMed ID: 11899615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of mushroom-forming fungi for the production of N-glycosylated therapeutic proteins.
    Berends E; Scholtmeijer K; Wösten HA; Bosch D; Lugones LG
    Trends Microbiol; 2009 Oct; 17(10):439-43. PubMed ID: 19758804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MacroGenics and Gilead Sciences to form new antibody alliance.
    Heseltine P
    Bioanalysis; 2013 Mar; 5(5):526. PubMed ID: 23544249
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody expression in protease-deficient strains of the methylotrophic yeast Ogataea minuta.
    Kuroda K; Kitagawa Y; Kobayashi K; Tsumura H; Komeda T; Mori E; Motoki K; Kataoka S; Chiba Y; Jigami Y
    FEMS Yeast Res; 2007 Dec; 7(8):1307-16. PubMed ID: 17714475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.